Contact this trialFirst, we need to learn more about you.
Antimalarial Drug
Hydroxychloroquine + Indapamide for Secondary Progressive Multiple Sclerosis
Recruiting3 awardsPhase 2
Calgary, Alberta
This trial tests if two medications, Hydroxychloroquine (HCQ) and Indapamide (IND), can help people with secondary progressive multiple sclerosis (SPMS). HCQ calms down certain brain cells that can harm nerves, while IND protects nerve cells from damage. The goal is to see if these drugs can slow down the worsening of disability in SPMS patients.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service